Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.
about
A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific RegionEvaluation of the Effectiveness of Pandemic Influenza A(H1N1) 2009 Vaccine Based on an Outbreak Investigation During the 2010-2011 Season in Korean Military CampsLow expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individualsDifferences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine.Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.Strategies for successful rapid trials of influenza vaccine.Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults.Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.
P2860
Q30352256-2D25A5AC-85F4-456B-8D53-1116C7592B60Q30354921-F466F3CA-2F0D-483E-BC0C-1A5D2ADF8A08Q30375875-01EF8BBF-E808-4BC7-BA5C-04C15D7271BFQ30400817-3C3F72AC-3ABA-442E-A3BC-1C56602AA63CQ30404358-7C3D68F6-36A2-4055-AFA2-FD1834B459B2Q30404989-977D6621-8405-4A18-9404-E4A779870051Q30406834-551E3C03-E56F-4AAF-8D89-2EA55A6F5827Q30407050-7F8F1F96-26AD-4D4C-93B2-3AA0A66F4CC2Q30407911-63E37023-BB7A-47A3-B521-A21D98D3DA99Q30421428-67E669A9-804E-4192-870C-BE54B02ADD65Q37900305-EC046A2D-A92F-4CE6-9CD8-F3E6C7EFBE7A
P2860
Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@ast
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@en
type
label
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@ast
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@en
prefLabel
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@ast
Immunogenicity and safety of i ...... ivated split vaccine in Korea.
@en
P2093
P1433
P1476
Immunogenicity and safety of i ...... tivated split vaccine in Korea
@en
P2093
Dae Won Park
Hee Jin Cheong
Ji Yun Noh
Joon Young Song
Jung Yeon Heo
Seong-Heon Wie
P304
P356
10.1016/J.VACCINE.2010.10.060
P407
P577
2010-11-04T00:00:00Z